Kishan Mehta - Jun 15, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 09:51 PM
Next filing
Jan 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +13K $0.00 13K Jun 15, 2021 Common Shares 13K $93.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option grant was made pursuant to the issuer's non-employee director compensation policy. The common shares underlying this option vest in three equal installments on June 15, 2022, 2023, and 2024, subject to the reporting person's continuous service with the issuer at each vesting date.